|
|
| Research article summary (published 29 Jun 2006): |
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.
Full Abstract
BACKGROUND:
Incidence of hepatocellular carcinoma in hepatitis C virus-related cirrhosis is 4% per year. Although cost-effective, current screening could be improved.
AIM:
To develop a statistical model including non-invasive parameters able to identify patients at high risk of developing hepatocellular carcinoma.
METHODS:
One hundred and fifty-eight patients (73F:85M) with compensated chronic hepatitis C virus liver disease underwent evaluation, including argyrophilic nucleolar organizer regions proliferation index, and were followed up for 56.18 +/- 1.44 months.
RESULTS:
Fifty-six patients had chronic hepatitis without cirrhosis and low argyrophilic nucleolar organizer regions proliferation index (< or =25%), 65 had hepatitis C virus-related cirrhosis and low argyrophilic nucleolar organizer regions proliferation index and 37 had hepatitis C virus-related cirrhosis and high argyrophilic nucleolar organizer regions proliferation index (>25%). Groups were similar for gender and viral genotype distribution. None of the patients with chronic hepatitis without cirrhosis developed hepatocellular carcinoma, compared with 6.1% of low argyrophilic nucleolar organizer regions proliferation index and 30.6% of high argyrophilic nucleolar organizer regions proliferation index (P = 0.002). By multivariable logistic regression analysis, the following parameters were independently associated with hepatocellular carcinoma development and used for the development of the statistical model:
platelets (OR 0.98), gamma-globulins (OR 0.111), alanine aminotransferase/aspartate aminotransferase ratio (OR 0.07), serum ferritin (OR 1.0) and ultrasonographic pattern (coarse OR 2.9, coarse nodular OR 10.12). The statistical model properly allocated 95.9% of patients with low argyrophilic nucleolar organizer regions proliferation index and 72.2% of patients with high argyrophilic nucleolar organizer regions proliferation index.
CONCLUSIONS:
The model, to be validated in large prospective studies, may help tailoring screening according to the risk of hepatocellular carcinoma development.
Learn Faster Today Improve your study skills
Author information
Author/s: Azzaroli, F (F); Colecchia, A (A); Colecchi, A (A); Lodato, F (F); Trerč, D (D); Bacchi Reggiani, M L (ML); Festi, D (D); Prati, G M (GM); Accogli, E (E); Casanova, S (S); Derenzini, M (M); Roda, E (E); Mazzella, G (G);
Affiliation: Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy. azzaroli(-atsign-)med.unibo.it
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: Alimentary pharmacology & therapeutics (Aliment Pharmacol Ther), published in England. (Language: eng)
Reference: 2006-Jul; vol 24 (issue 1) : pp 129-36
Dates: Created 2006/06/28; Completed 2007/01/18; Revised 2007/01/19;
PMID: 16803611, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
Comments and Corrections
ErratumIn: Aliment Pharmacol Ther. 2006 Jul 15;24(2):439. (Note: Colecchi, A [corrected to Colecchia, A])
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.
27 Feb 2003 - Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.
30 Mar 2004 - Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
30 Mar 2005 - Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis.
30 Aug 2007 - Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.
29 Nov 2007 - Cytokine levels of TGF-beta, IL-10, and sTNFalphaRII in type C chronic liver disease.
12 Dec 2007 - Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis.
5 Feb 2008 - Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection.
30 Dec 2002 - CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
8 Apr 2003 - Clinical features of patients with HCC who are negative for both HBV and HCV markers.
30 Oct 2003
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.